Skip to content

Monopar Therapeutics MNPR Long-term investments

Long-term investments at other companies

PennyMac Financial Services, Inc. logo
PennyMac Financial Services, Inc.PFSI
$434.22M-2.1%
Groupon, Inc. logo
Groupon, Inc.GRPN
$74.82M0.0%
Hippo Holdings logo
Hippo HoldingsHIPO
$298.7M+40.8%
Capital City Bank Group logo
Capital City Bank GroupCCBG
$1.02B+5.2%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$22.52M+125%
Universal Insurance Holdings logo
Universal Insurance HoldingsUVE
$1.54B+7.6%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M-62.2%
Net income-$3.9M-48.3%
EPS (diluted)-$0.19

Balance sheet

See full
Cash & equivalents$52.5M+32.3%
Total debt$230.4K+2,692%
Total equity$135.4M+153%
Total assets$138.0M+150%

Cash flow

See full
Operating cash flow-$3.5M+38.7%

Valuation

See full
Market cap$587.04M+192%
Enterprise value$534.72M+232%

Returns & leverage

See full
Return on equity-15.9%-6.6pp
Debt / equity0.0×
Current ratio56×

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Investments.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's long-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Monopar Therapeutics's long-term investments?
Monopar Therapeutics (MNPR) reported long-term investments of $84.95M in Q1 2026.
How has Monopar Therapeutics's long-term investments changed year-over-year?
Monopar Therapeutics's long-term investments increased by 472.4% year-over-year, from $14.84M to $84.95M.
What does long-term investments mean?
Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.